SH Pharma Moves to Divest 51% Stake in Subsidiary Pharmacy via Public Listing

Stock News08-24

Shanghai Pharmaceuticals Holding Co., Ltd. (SH Pharma) has announced that its wholly-owned subsidiary, Shanghai Pharma Holding Co., Ltd., plans to transfer its 51% equity interest in its controlled subsidiary, Shanghai Shangyao Xinte Dong'an Pharmacy Co., Ltd., through a public listing on a property rights exchange. The proposed listing price for the stake is set at RMB 178.5 million.

The transaction represents a key strategic move by SH Pharma to advance the overall development of its new retail business and further enhance its competitive edge. The initiative aims to integrate and dispose of specialized pharmacy resources within the SH Pharma system, optimize resource allocation in the new retail sector, and strengthen resource synergy and value realization across its specialized pharmacy segment.

By doing so, the company seeks to comprehensively improve its retail terminal service capabilities, operational efficiency, market value, and core competitiveness. Additionally, the move supports a sharper focus on existing core business areas, optimizes the business structure, and enhances resource allocation efficiency, contributing to the company's pursuit of high-quality development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1162655629?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-24 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162655629","market":"us","top_or_hot":-1,"title":"SH Pharma Moves to Divest 51% Stake in Subsidiary Pharmacy via Public Listing","media":"Stock News","content":"<p>Shanghai Pharmaceuticals Holding Co., Ltd. (SH Pharma) has announced that its wholly-owned subsidiary, Shanghai Pharma Holding Co., Ltd., plans to transfer its 51% equity interest in its controlled subsidiary, Shanghai Shangyao Xinte Dong'an Pharmacy Co., Ltd., through a public listing on a property rights exchange. The proposed listing price for the stake is set at RMB 178.5 million.<br><br>The transaction represents a key strategic move by <b>SH Pharma</b> to advance the overall development of its new retail business and further enhance its competitive edge. The initiative aims to integrate and dispose of specialized pharmacy resources within the SH Pharma system, optimize resource allocation in the new retail sector, and strengthen resource synergy and value realization across its specialized pharmacy segment.<br><br>By doing so, the company seeks to comprehensively improve its retail terminal service capabilities, operational efficiency, market value, and core competitiveness. Additionally, the move supports a sharper focus on existing core business areas, optimizes the business structure, and enhances resource allocation efficiency, contributing to the company's pursuit of high-quality development.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SH Pharma Moves to Divest 51% Stake in Subsidiary Pharmacy via Public Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSH Pharma Moves to Divest 51% Stake in Subsidiary Pharmacy via Public Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-24 20:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Pharmaceuticals Holding Co., Ltd. (SH Pharma) has announced that its wholly-owned subsidiary, Shanghai Pharma Holding Co., Ltd., plans to transfer its 51% equity interest in its controlled subsidiary, Shanghai Shangyao Xinte Dong'an Pharmacy Co., Ltd., through a public listing on a property rights exchange. The proposed listing price for the stake is set at RMB 178.5 million.<br><br>The transaction represents a key strategic move by <b>SH Pharma</b> to advance the overall development of its new retail business and further enhance its competitive edge. The initiative aims to integrate and dispose of specialized pharmacy resources within the SH Pharma system, optimize resource allocation in the new retail sector, and strengthen resource synergy and value realization across its specialized pharmacy segment.<br><br>By doing so, the company seeks to comprehensively improve its retail terminal service capabilities, operational efficiency, market value, and core competitiveness. Additionally, the move supports a sharper focus on existing core business areas, optimizes the business structure, and enhances resource allocation efficiency, contributing to the company's pursuit of high-quality development.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0099","symbol_name":"上海本地重组","start_time":0,"source_url":"","article_id":"1162655629","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162655629","pubTimestamp":1787574628,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH Pharma) has announced that its wholly-owned subsidiary, Shanghai Pharma Holding Co., Ltd., plans to transfer its 51% equity interest in its controlled...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601607":"上海医药","BK0099":"上海本地重组","BK0097":"医药电商","BK0028":"国家队","BK0020":"浦东新区","BK1197":"保健护理产品经销商","BK0183":"MSCI概念","BK0209":"零售","BK0184":"上海国资改革","BK0188":"融资融券","BK0012":"证金概念","BK0175":"白马股","BK0196":"行业龙头","02607":"上海医药","BK0187":"一线龙头"},"translate_title":"SH Pharma拟通过公开上市剥离子公司药房51%股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1,"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH Pharma) has announced that its wholly-owned subsidiary, Shanghai Pharma Holding Co., Ltd., plans to transfer its 51% equity interest in its controlled subsidiary, Shanghai Shangyao Xinte Dong'an Pharmacy Co., Ltd., through a public listing on a property rights exchange. The proposed listing price for the stake is set at RMB 178.5 million.The transaction represents a key strategic move by SH Pharma to advance the overall development of its new retail business and further enhance its competitive edge. The initiative aims to integrate and dispose of specialized pharmacy resources within the SH Pharma system, optimize resource allocation in the new retail sector, and strengthen resource synergy and value realization across its specialized pharmacy segment.By doing so, the company seeks to comprehensively improve its retail terminal service capabilities, operational efficiency, market value, and core competitiveness. Additionally, the move supports a sharper focus on existing core business areas, optimizes the business structure, and enhances resource allocation efficiency, contributing to the company's pursuit of high-quality development.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1162655629","isCrawlerRequest":true}